Odyssey Therapeutics (ODTX) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,560.00−0.00%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Odyssey Therapeutics Inc (ODTX) Stock Price, Quote, News & History

ODTXNASDAQ

Trade with Public

Trade with Public

$19.00

0.884.86%

Last update: Oct 9, 3:59 PM

$19.42

1.307.17%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$18.72

Close

$19.00

Volume / Avg.

293.21K / 273.69K

Day Range

$19.00 - $19.00

52 Wk Range

15.10 - 29.05

Market Cap

$870.82M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

5.24%

Days to Cover

10.78

Recent Odyssey Therapeutics Inc News

This Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Analysts initiate coverage and change ratings on top stocks like ASND, DOCN, ODTX, MT, and NVCT. See their price targets and views on these stocks.

Avi Kapoor

This Oppenheimer Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names: ODTX, MOBI, MANE. See analyst ratings page for all changes. MOBI target prices: $16, $19, $31

Avi Kapoor

Doximity, Aeluma, PDF Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures rise on Dow gaining 200 points. Doximity (DOCS) shares drop 21.3% after reporting mixed Q4 results and weak guidance. Other stocks also decline in pre-market trading.

Avi Kapoor

PRO
Odyssey Therapeutics shares are trading higher after Raymond James initiated coverage on the stock with an Outperform rating and announced a $42 price target.

Benzinga Newsdesk

PRO
Raymond James Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $42

Raymond James analyst Thomas Deal initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Outperform rating and announces Price Target of $42.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-132.13M

Investing Cash Flow (TTM)

-338.02M

Financing Cash Flow (TTM)

389.37M

Free Cash Flow (TTM)

-132.74M

Capital Expenditure (TTM)

-610.00K

Net Change in Cash (TTM)

-80.78M

Analyst Trends and Forecast

6

Jun

2

Aug

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$584.11M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

8755.88

PB Ratio (TTM)

2.07

Earnings Yield % (TTM)

-18.46%

Earnings Yield % (FWD)

-28.34%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$8.76

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$82.03M

Debt to Equity

0.06

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-